Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Allergan
Company Monitoring Page for Allergan
latest headlines for company on cafepharma
Here’s Why Valeant Pharmaceuticals Intl Inc Will Strike More Acquisition Deals In 2015
Bidness Etc.
Tue, 02/24/15 - 09:40 am
Tags:
Valeant Pharmaceuticals
,
M&A
,
Actavis
,
Allergan
,
Salix
Pharma's top 10 M&A deals of 2014
Fierce Pharma
Thu, 02/19/15 - 07:51 am
Tags:
M&A
,
Actavis
,
Allergan
,
Forest Labs
,
GSK
,
Novartis
,
Bayer
,
Merck
,
Cubist Pharma
,
Roche
,
InterMune
,
Mylan Labs
,
Abbott Labs
,
Questcor
,
Mallinckrodt
,
Eli Lilly
,
Sun Pharma
,
Ranbaxy
Actavis plans name change to Allergan
Yahoo/AP
Wed, 02/18/15 - 08:46 am
Tags:
Actavis
,
Allergan
,
M&A
Think Allergan CEO's 'all-consuming' Valeant fight won't happen to you? Think again
Fierce Pharma
Tue, 02/10/15 - 06:43 pm
Tags:
Allergan
,
Pharma CEOs
,
Valeant Pharmaceuticals
,
M&A
,
David Pyott
Actavis Plc To Divest US Rights For Doryx Before Closing Allergan, Inc. Deal
Bidness Etc.
Tue, 02/10/15 - 08:51 am
Tags:
Actavis
,
DORYX
,
M&A
,
Allergan
Strong earnings suggest Allergan sold too cheap, analyst says
Fierce Pharma
Fri, 02/6/15 - 10:26 am
Tags:
Allergan
,
earnings
,
M&A
,
Actavis
Allergan, Inc. (AGN) Reports Upbeat Q4 Profit On Higher Sales
Bidness Etc.
Thu, 02/5/15 - 09:07 am
Tags:
Allergan
,
earnings
How the Actavis deal upended Allergan No. 2's CEO ambitions
Yahoo/Reuters
Wed, 02/4/15 - 09:58 am
Tags:
Allergan
,
Amgen
,
M&A
,
Doug Ingram
Actavis expects profit to beat expectations
Marketwatch
Mon, 01/12/15 - 09:48 am
Tags:
Actavis
,
Allergan
Valeant Surges on Higher Profit Forecast, Outlook for More Deals
Bloomberg
Sat, 01/10/15 - 01:06 pm
Tags:
Valeant Pharmaceuticals
,
Allergan
,
Actavis
,
M&A
Drug Buying Spree Still Bustling; Pfizer Leads Hunt
Bloomberg
Wed, 01/7/15 - 08:31 am
Tags:
Pfizer
,
Actavis
,
Allergan
,
Valeant Pharmaceuticals
,
M&A
Will Allergan Buy Help Actavis Extend Growth Streak?
Investors.com
Tue, 01/6/15 - 06:57 pm
Tags:
Allergan
,
Actavis
,
M&A
The Allergan Acquisition Is A Game-Changer For Actavis: Stock Could Double In Five Years
Seeking Alpha
Mon, 12/29/14 - 09:16 pm
Tags:
Allergan
,
Actavis
,
M&A
Bill Ackman Seeks To Have Allergan Inc Insider-Trading Lawsuit Dismissed
Bidness Etc.
Mon, 12/29/14 - 11:00 am
Tags:
Allergan
,
M&A
,
Bill Ackman
,
insider trading
,
Valeant Pharmaceuticals
Big pharma cashes in as M&A fever sweeps sector
FT.com
Fri, 12/26/14 - 09:57 am
Tags:
M&A
,
Allergan
,
Actavis
,
Valeant Pharmaceuticals
,
AbbVie
,
Shire
,
Pfizer
,
AstraZeneca
Activis to Replace Most Allergan Executives After Deal
Bloomberg
Tue, 12/16/14 - 10:20 am
Tags:
Activis
,
Allergan
,
executives
,
M&A
Herb Greenberg: What's Next for Valeant After Its Botched Bid for Allergan
TheStreet.com
Wed, 12/10/14 - 09:47 am
Tags:
Valeant Pharmaceuticals
,
M&A
,
Allergan
Ackman's Pershing Square still holds 26.6 million Allergan shares
Yahoo/Reuters
Wed, 11/26/14 - 11:35 am
Tags:
Bill Ackman
,
Allergan
,
M&A
,
Valeant Pharmaceuticals
,
Actavis
Actavis Plans Job Cuts, China Expansion for Allergan
Bloomberg
Tue, 11/25/14 - 09:40 am
Tags:
Actavis
,
Allergan
,
M&A
,
layoffs
,
China
[video]Actavis-Allergan: Anatomy of a $66B Deal
Bloomberg
Mon, 11/24/14 - 10:14 am
Tags:
Actavis
,
Allergan
,
M&A
Pages
« first
‹ previous
…
32
33
34
35
36
37
38
39
40
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.